NCT02553785View on ClinicalTrials.gov

Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Heart Failure
Interventions
DEVICE

Revivent TC

Trial Locations (1)

Unknown

Hospital Clinic University of Barcelona, Barcelona

Sponsors

Lead Sponsor

BioVentrix
All Listed Sponsors
collaborator

Ohio State University

OTHER

lead

BioVentrix

INDUSTRY

NCT02553785 - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy | Biotech Hunter | Biotech Hunter